Business Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
📈
AI Sentiment
Highly Positive
9/10
Estrella Immunopharma Inc. News
Latest updates and market news for ESLA
1 news
Mar 23 - Mar 29, 2026
Page 1
Share this news page